BioTrack

Jason Holman Joined Sep 18, 2013

My primary focus is small Market Cap Bio Tech companies with intriguing pipelines that have large growth potential. I attempt to hold >50% of positions as LONG unless there is negative data, mgmt. concerns, or known negative events.